Phortress
Phortress is a high affinity AhR ligand that elicits antitumor activity by inducing transcription of CYP1A1[1][2].
Product Specifications
CAS Number
328087-38-3
Product Name Alternative
NSC 710305
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/phortress.html
Purity
98.19
Solubility
DMSO : 125 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=CC=C(C2=NC3=CC(F)=CC=C3S2)C=C1C)[C@@H](N)CCCCN.[H]Cl.[H]Cl
Molecular Formula
C20H25Cl2FN4OS
Molecular Weight
459.41
Precautions
H302, H315, H319
References & Citations
[1]Bradshaw TD, et al. In vitro evaluation of amino acid prodrugs of novel antitumour 2- (4-amino-3-methylphenyl) benzothiazoles. Br J Cancer. 2002 Apr 22;86 (8) :1348-54.|[2]Bradshaw TD, Westwell AD. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr Med Chem. 2004 Apr;11 (8) :1009-21.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CYP1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb3142866-01 50 mg
Recombinant endoglycoceramidase I assisted by activator II
Sign In for Pricing
View Details orb3142866-02 10 mg
Recombinant endoglycoceramidase I assisted by activator II
Sign In for Pricing
View Details 
